Low density lipoprotein and cardiovascular risk
Pro Research Analysisby 
Searched over 200M research papers
Low-Density Lipoprotein (LDL) Cholesterol and Cardiovascular Disease Risk
LDL Cholesterol as a Causal Factor in Cardiovascular Disease
Extensive genetic, epidemiological, and clinical evidence shows that low-density lipoprotein cholesterol (LDL-C) is a direct cause of atherosclerotic cardiovascular disease (ASCVD). Studies consistently demonstrate a dose-dependent, log-linear relationship between the amount and duration of LDL-C exposure and ASCVD risk. Lowering LDL-C by any means reduces ASCVD events in proportion to the degree and duration of LDL-C reduction, confirming LDL’s causal role in cardiovascular disease .
LDL-C and Cardiovascular Mortality in Low-Risk Populations
Even among individuals with a low 10-year risk of ASCVD, higher LDL-C levels are independently associated with increased long-term risk of cardiovascular and coronary heart disease mortality. LDL-C levels of 160 mg/dL or higher are linked to a 50% to 80% greater risk of cardiovascular death, suggesting that LDL-C is a relevant risk factor even in populations considered low risk by standard assessments .
LDL-C, Coronary Atherosclerosis, and Event Prediction
The association between LDL-C and future ASCVD events is strongest in individuals with evidence of coronary atherosclerosis, such as coronary artery calcification (CAC). In people without CAC, LDL-C is not significantly linked to ASCVD events, while in those with CAC, higher LDL-C levels markedly increase risk. This highlights the importance of individualized risk assessment based on both LDL-C levels and the presence of atherosclerosis .
LDL Particle Number, Size, and Atherogenicity
Beyond LDL-C concentration, the number and characteristics of LDL particles are important. Individuals with a higher number of LDL particles, especially small dense LDL (sdLDL), have a greater risk of coronary heart disease. However, it is the total number of LDL particles, rather than their size alone, that is a strong, independent predictor of cardiovascular risk . Direct measurement of sdLDL-C, particularly values ≥50 mg/dL, is also an independent risk enhancer for ASCVD across different sex and race groups . Elevated sdLDL-C is especially associated with myocardial infarction risk .
Oxidized LDL and Emerging Biomarkers
Oxidized LDL (oxLDL) is recognized as a key factor in the development and progression of atherosclerosis. Elevated oxLDL levels are associated with increased cardiovascular risk, and new biomarkers related to LDL atherogenicity may help predict future ischemic events. Targeting oxLDL and its receptor (LOX-1) is being explored for innovative therapies and diagnostics .
LDL-C, Lipoprotein(a), and Residual Cardiovascular Risk
Lipoprotein(a) [Lp(a)] is another independent risk factor for ASCVD. Elevated Lp(a) increases cardiovascular risk even when LDL-C is low or well-controlled with statin therapy. The risk is highest when both LDL-C and Lp(a) are elevated, and lowering LDL-C does not fully offset the risk associated with high Lp(a) 47.
Cholesterol Content of Triglyceride-Rich and Small Dense LDL Particles
The cholesterol content of triglyceride-rich lipoproteins (TRL-C) and sdLDL-C independently contributes to atherosclerotic risk. TRL-C is strongly associated with future myocardial infarction and peripheral artery disease, while sdLDL-C is particularly linked to myocardial infarction. These associations are independent of traditional LDL-C measurements and other risk factors .
LDL-C and Cardiovascular Risk Across Populations
The relationship between LDL-C and cardiovascular mortality can vary by population and risk level. In some large cohorts, a U-shaped or J-shaped association has been observed, suggesting that both very low and very high LDL-C levels may be linked to increased mortality, and that lipid management strategies should be tailored to individual risk profiles .
Conclusion
LDL cholesterol is a well-established, causal risk factor for atherosclerotic cardiovascular disease. The risk is influenced not only by LDL-C levels but also by LDL particle number, size, and modifications such as oxidation. Additional factors like Lp(a) and sdLDL-C further contribute to residual cardiovascular risk, even when LDL-C is well controlled. Comprehensive assessment of LDL-related biomarkers and individualized risk stratification are essential for effective prevention and management of cardiovascular disease 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic